These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 17725615

  • 1. Visual outcome and cataract development after allogeneic stem-cell transplantation in children.
    Fahnehjelm KT, Törnquist AL, Olsson M, Winiarski J.
    Acta Ophthalmol Scand; 2007 Nov; 85(7):724-33. PubMed ID: 17725615
    [Abstract] [Full Text] [Related]

  • 2. Dry-eye syndrome after allogeneic stem-cell transplantation in children.
    Fahnehjelm KT, Törnquist AL, Winiarski J.
    Acta Ophthalmol; 2008 May; 86(3):253-8. PubMed ID: 18093259
    [Abstract] [Full Text] [Related]

  • 3. Cataracts after autologous bone marrow transplantation in children.
    Frisk P, Hagberg H, Mandahl A, Söderberg P, Lönnerholm G.
    Acta Paediatr; 2000 Jul; 89(7):814-9. PubMed ID: 10943964
    [Abstract] [Full Text] [Related]

  • 4. Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation.
    Aristei C, Alessandro M, Santucci A, Aversa F, Tabillo A, Carotti A, Latini RA, Cagini C, Latini P.
    Bone Marrow Transplant; 2002 Mar; 29(6):503-7. PubMed ID: 11960270
    [Abstract] [Full Text] [Related]

  • 5. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF, Al-Ghamdi A, Al-Mohareb F, Ayas M, Chaudhri N, Al-Sharif F, Al-Zahrani H, Mohammed SY, Nassar A, Aljurf M.
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [Abstract] [Full Text] [Related]

  • 6. Visual field results and optic disc morphology in patients treated with allogeneic stem-cell transplantation in childhood.
    Törnquist AL, Olsson M, Martin L, Winiarski J, Fahnehjelm KT.
    Acta Ophthalmol; 2011 Feb; 89(1):62-9. PubMed ID: 20064124
    [Abstract] [Full Text] [Related]

  • 7. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P, Piñana JL, Valcárcel D, Querol L, Martino R, Sureda A, Briones J, Delgado J, Brunet S, Sierra J.
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [Abstract] [Full Text] [Related]

  • 8. Incidence of cataracts after single fraction total body irradiation: the role of steroids and graft versus host disease.
    Hamon MD, Gale RF, Macdonald ID, Smith OP, Collis CH, Skeggs DB, Gandhi L, Prentice HG.
    Bone Marrow Transplant; 1993 Sep; 12(3):233-6. PubMed ID: 8241982
    [Abstract] [Full Text] [Related]

  • 9. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF, Fan ZP, Zhang Y, Jiang ZJ, Wang CY, Xu D, Sun J, Xiao Y, Tan H.
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [Abstract] [Full Text] [Related]

  • 10. Neuropsychological outcome in very young hematopoietic SCT recipients in relation to pretransplant conditioning.
    Smedler AC, Winiarski J.
    Bone Marrow Transplant; 2008 Oct; 42(8):515-22. PubMed ID: 18679374
    [Abstract] [Full Text] [Related]

  • 11. Ocular graft-versus-host disease after allogeneic stem cell transplantation.
    Westeneng AC, Hettinga Y, Lokhorst H, Verdonck L, van Dorp S, Rothova A.
    Cornea; 2010 Jul; 29(7):758-63. PubMed ID: 20489577
    [Abstract] [Full Text] [Related]

  • 12. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A, Kondo T, Yamamoto S, Sugita J, Onozawa M, Kahata K, Endo T, Shiratori S, Ota S, Obara M, Wakasa K, Takahata M, Takeda Y, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M.
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [Abstract] [Full Text] [Related]

  • 13. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant.
    Faraci M, Barra S, Cohen A, Lanino E, Grisolia F, Miano M, Foppiano F, Sacco O, Cabria M, De Marco R, Stella G, Dallorso S, Bagnasco F, Vitale V, Dini G, Haupt R.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1568-75. PubMed ID: 15990246
    [Abstract] [Full Text] [Related]

  • 14. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties.
    Uderzo C, Pillon M, Corti P, Tridello G, Tana F, Zintl F, Nysom K, Galambrun C, Fagioli F, Varotto S, Messina C, Verdeguer A, Urban C, Faraci M, Dini G, Fedeli S, Tichelli A, Rovelli A, Socié G.
    Bone Marrow Transplant; 2007 Jun 01; 39(11):667-75. PubMed ID: 17401396
    [Abstract] [Full Text] [Related]

  • 15. The development of cataract in children as a late side-effect of bone marrow transplantation.
    Calissendorff B, Bolme P, el Azazi M.
    Bone Marrow Transplant; 1991 Jun 01; 7(6):427-9. PubMed ID: 1873589
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y, Suzuki R, Kuwatsuka Y, Yasuda T, Takahashi T, Tsujimura A, Sugimoto K, Oba T, Terakura S, Atsuta Y, Murata M, Ito M, Kodera Y, Miyamura K.
    Biol Blood Marrow Transplant; 2008 Jan 01; 14(1):43-9. PubMed ID: 18158960
    [Abstract] [Full Text] [Related]

  • 17. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D, Martino R, Caballero D, Martin J, Ferra C, Nieto JB, Sampol A, Bernal MT, Piñana JL, Vazquez L, Ribera JM, Besalduch J, Moraleda JM, Carrera D, Brunet MS, Perez-Simón JA, Sierra J.
    J Clin Oncol; 2008 Feb 01; 26(4):577-84. PubMed ID: 18086801
    [Abstract] [Full Text] [Related]

  • 18. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Feb 01; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 19. Agenesis and microdontia of permanent teeth as late adverse effects after stem cell transplantation in young children.
    Hölttä P, Alaluusua S, Saarinen-Pihkala UM, Peltola J, Hovi L.
    Cancer; 2005 Jan 01; 103(1):181-90. PubMed ID: 15540242
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies.
    Ferry C, Gemayel G, Rocha V, Labopin M, Esperou H, Robin M, de Latour RP, Ribaud P, Devergie A, Leblanc T, Gluckman E, Baruchel A, Socié G.
    Bone Marrow Transplant; 2007 Aug 01; 40(3):219-24. PubMed ID: 17530002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.